Specific suppression of interleukin-2 biosynthesis by synthetic antisense oligodeoxynucleotides does not influence allograft rejection.
Yun
S
S
Department of Clinical Sciences, Institute of Liver Studies, Guy's, King's and St Thomas' School of Medicine, King's College Hospital, London, UK.
Sawyer
G
G
Zhang
X
X
Gustafsson
K
K
Fabre
J W
JW
D000818:Animals; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D007376:Interleukin-2 / Q000096:biosynthesis* / Q000494:pharmacology; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology*; D051381:Rats; D023001:Transplantation Tolerance / Q000276:immunology*
D007376:Interleukin-2; D020319:Oligodeoxyribonucleotides, Antisense